Daskal Ilan — SEC insider filings
SEC reporting owner CIK 1446964. 26 insider filings on record with FilingPulse; latest filed 2026-09-23.
Transaction summary — filings shown
Covers all 26 filings on record, filed 2020-09-04 to 2026-09-23. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 13 legs across 7 filings — 313,995 shares, $8,244,028 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 98.
- Largest priced transaction: sale of 105,191 shares @ $17.43 ($1,833,479) in VIAVI SOLUTIONS INC., filed 2025-12-03.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| VIAVI SOLUTIONS INC. (VIAV) | EVP, CFO | 12 | — | 6 legs · 308,385 sh · $5,777,600 | 58 |
| BIO-RAD LABORATORIES, INC. (BIO) | EVP, Chief Financial Officer | 10 | — | 6 legs · 3,110 sh · $2,397,778 | 37 |
| NATUS MEDICAL INC (NTUS) | Director | 4 | — | 1 leg · 2,500 sh · $68,650 | 3 |
Insider filings — Daskal Ilan
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-23 | 4 | VIAVI SOLUTIONS INC. (VIAV) | Option exercise (M): 82,671 @ $0 · Tax withholding (F): 37,285 @ $36.40 · Option exercise (M): 71,127 @ $0 · Tax withholding (F): 32,079 @ $36.40 · Option exercise (M): 82,671 (derivative) @ $0 · Option exercise (M): 71,127 (derivative) @ $0 · +2 more | EDGAR |
| 2026-08-31 | 4 | VIAVI SOLUTIONS INC. (VIAV) | Sale (S): 30,257 @ $36.29 · Sale (S): 26,033 @ $36.29 | EDGAR |
| 2026-08-31 | 4 | VIAVI SOLUTIONS INC. (VIAV) | Option exercise (M): 55,114 @ $0 · Tax withholding (F): 24,857 @ $36.54 · Option exercise (M): 47,420 @ $0 · Tax withholding (F): 21,387 @ $36.54 · Option exercise (M): 55,114 (derivative) @ $0 · Option exercise (M): 47,420 (derivative) @ $0 · +2 more | EDGAR |
| 2025-12-03 | 4 | VIAVI SOLUTIONS INC. (VIAV) | Sale (S): 25,100 @ $17.84 · Sale (S): 39,709 @ $17.42 · Sale (S): 105,191 @ $17.43 | EDGAR |
| 2025-12-01 | 4 | VIAVI SOLUTIONS INC. (VIAV) | Option exercise (M): 62,645 @ $0 · Tax withholding (F): 28,253 @ $17.94 · Option exercise (M): 35,984 @ $0 · Tax withholding (F): 16,229 @ $17.94 · Option exercise (M): 65,944 @ $0 · Tax withholding (F): 29,741 @ $17.94 · +6 more | EDGAR |
| 2025-09-25 | 4 | VIAVI SOLUTIONS INC. (VIAV) | Option exercise (M): 70,545 @ $0 · Tax withholding (F): 31,816 @ $12.41 · Option exercise (M): 70,545 (derivative) @ $0 · Grant/award (A): 35,984 (derivative) @ $0 · Grant/award (A): 62,645 (derivative) @ $0 | EDGAR |
| 2025-09-02 | 4 | VIAVI SOLUTIONS INC. (VIAV) | Option exercise (M): 55,115 @ $0 · Tax withholding (F): 24,857 @ $11.27 · Option exercise (M): 55,115 (derivative) @ $0 · Grant/award (A): 142,258 (derivative) @ $0 · Grant/award (A): 142,258 (derivative) @ $0 | EDGAR |
| 2025-06-06 | 4 | VIAVI SOLUTIONS INC. (VIAV) | Sale (S): 82,095 @ $9.28 | EDGAR |
| 2024-12-02 | 4 | VIAVI SOLUTIONS INC. (VIAV) | Option exercise (M): 39,783 @ $0 · Tax withholding (F): 20,162 @ $9.88 · Option exercise (M): 22,851 @ $0 · Tax withholding (F): 11,581 @ $9.88 · Option exercise (M): 65,944 @ $0 · Tax withholding (F): 33,421 @ $9.88 · +6 more | EDGAR |
| 2024-09-26 | 4 | VIAVI SOLUTIONS INC. (VIAV) | Grant/award (A): 39,783 (derivative) @ $0 · Grant/award (A): 22,851 (derivative) @ $0 | EDGAR |
| 2024-08-30 | 4 | VIAVI SOLUTIONS INC. (VIAV) | Grant/award (A): 165,343 (derivative) @ $0 · Grant/award (A): 165,343 (derivative) @ $0 | EDGAR |
| 2023-11-30 | 4 | VIAVI SOLUTIONS INC. (VIAV) | Grant/award (A): 113,636 (derivative) @ $0 · Grant/award (A): 263,774 (derivative) @ $0 · Grant/award (A): 113,636 (derivative) @ $0 · Grant/award (A): 263,774 (derivative) @ $0 | EDGAR |
| 2023-09-06 | 4 | BIO-RAD LABORATORIES, INC. (BIO) | Option exercise (M): 694 @ $0 · Tax withholding (F): 240 @ $394.60 · Option exercise (M): 456 @ $0 · Tax withholding (F): 209 @ $394.60 · Option exercise (M): 542 @ $0 · Tax withholding (F): 269 @ $394.60 · +4 more | EDGAR |
| 2023-04-11 | 4 | BIO-RAD LABORATORIES, INC. (BIO) | Option exercise (M): 700 @ $0 · Tax withholding (F): 243 @ $466.24 · Option exercise (M): 700 (derivative) @ $0 | EDGAR |
| 2022-09-07 | 4 | BIO-RAD LABORATORIES, INC. (BIO) | Option exercise (M): 541 @ $0 · Tax withholding (F): 269 @ $478.32 · Option exercise (M): 541 (derivative) @ $0 | EDGAR |
| 2022-09-06 | 4 | BIO-RAD LABORATORIES, INC. (BIO) | Option exercise (M): 455 @ $0 · Tax withholding (F): 226 @ $486.25 · Grant/award (A): 2,776 (derivative) @ $0 · Option exercise (M): 455 (derivative) @ $0 | EDGAR |
| 2022-07-21 | 4 | NATUS MEDICAL INC (NTUS) | Disposition to issuer (D): 18,937 @ $33.50 | EDGAR |
| 2022-06-17 | 4 | NATUS MEDICAL INC (NTUS) | Grant/award (A): 5,075 @ $0 | EDGAR |
| 2022-04-11 | 4 | BIO-RAD LABORATORIES, INC. (BIO) | Option exercise (M): 700 @ $0 · Tax withholding (F): 257 @ $597.16 · Option exercise (M): 700 (derivative) @ $0 | EDGAR |
| 2021-09-08 | 4 | BIO-RAD LABORATORIES, INC. (BIO) | Sale (S): 270 @ $820.06 | EDGAR |
| 2021-09-03 | 4 | BIO-RAD LABORATORIES, INC. (BIO) | Option exercise (M): 540 @ $524.30 · Sale (S): 440 @ $828 · Sale (S): 100 @ $828.01 · Option exercise (M): 541 @ $0 · Tax withholding (F): 269 @ $825.77 · Grant/award (A): 1,823 (derivative) @ $0 · +3 more | EDGAR |
| 2021-08-05 | 4 | BIO-RAD LABORATORIES, INC. (BIO) | Option exercise (M): 1,400 @ $309.84 · Sale (S): 857 @ $750.85 · Sale (S): 954 @ $751.98 · Sale (S): 489 @ $753.32 · Option exercise (M): 1,400 (derivative) @ $0 | EDGAR |
| 2021-06-21 | 4 | NATUS MEDICAL INC (NTUS) | Grant/award (A): 5,214 @ $28.77 | EDGAR |
| 2021-06-15 | 4 | NATUS MEDICAL INC (NTUS) | Sale (S): 2,500 @ $27.46 | EDGAR |
| 2021-04-09 | 4 | BIO-RAD LABORATORIES, INC. (BIO) | Option exercise (M): 700 @ $0 · Tax withholding (F): 250 @ $592.23 · Option exercise (M): 700 (derivative) @ $0 | EDGAR |
| 2020-09-04 | 4 | BIO-RAD LABORATORIES, INC. (BIO) | Grant/award (A): 2,166 (derivative) @ $0 · Grant/award (A): 2,166 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-09-04 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1446964 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs